- high-resolution terminology - matching measurements at high-resolution
Mitochondria-Targeted Drug Development
Description
The Mitochondria-Targeted Drug Development Summit was first established in 2021, as an online conference. Due to its success and unmatched focus, the 2nd edition returns to Boston this March 2022. This is the only industry-led meeting that unites key stakeholders under a mutual and ambitious objective of accelerating the discovery and development of novel drugs that target mitochondrial functions for chronic, primary mitochondrial diseases, muscular dystrophy, metabolic disorders, and neurodegenerative diseases. Join our speakers from GenSight Biologics, Abliva, Reneo Pharma, Mito BioPharma, Mitokinin and more with exciting networking opportunities, panel discussions and dedicated roundtables.
Abbreviation: hansonwade
Reference: hansonwade
MitoPedia topics: MitoGlobal Organizations
Contact details
- T: (+1) 617 455 4188
- E-mail: [email protected]
Conference address
- Hyatt Regency Boston / Cambridge
- 575 Memorial Dr
- Cambridge
- MA 02139
- United States
Links:
Listed as a MitoGlobal Society.
| MitoGlobal | MitoEAGLE | MitoGlobal Societies | MiPsociety | ASMRM | MitoGlobal Events | MitoGlobal first |
